Wall Street Analysts Think Jazz (JAZZ) Could Surge 51.8%: Read This Before Placing a Bet

Shares of Jazz Pharmaceuticals (JAZZ) have gained 5.6% over the past four weeks to close the last trading session at $115.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$175.56 indicates a potential upside of 51.8%. The average comprises 18 short-term price targets ranging from a low of $113 to a high of$230, with a standard deviation of $33.87. While the lowest estimate i ...